Compounds > fr 66973
Page last updated: 2024-09-04

fr 66973 and Lung Neoplasms

fr 66973 has been researched along with Lung Neoplasms in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19902 (66.67)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tsukagoshi, S1
Fujiwara, Y; Horiuchi, N; Minato, K; Nakagawa, K; Nezu, K; Ohe, Y; Saijo, N; Sasaki, Y1
Chiang, CD; Eguchi, K; Kanzawa, F; Matsushima, Y; Morinaga, S; Nakagawa, K; Nakano, H; Sasaki, Y; Takahashi, H; Tsuchiya, R1

Other Studies

3 other study(ies) available for fr 66973 and Lung Neoplasms

ArticleYear
[Antitumor candidate compounds under clinical trials in Japan].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1990, Volume: 17, Issue:3 Pt 1

    Topics: Animals; Anthracyclines; Antibiotics, Antineoplastic; Antineoplastic Agents; Bleomycin; Cisplatin; Leukemia P388; Lung Neoplasms; Melanoma, Experimental; Mice; Oxazines

1990
In vitro antitumor activity of mitomycin C derivative (RM-49) and new anticancer antibiotics (FK973) against lung cancer cell lines determined by tetrazolium dye (MTT) assay.
    Cancer chemotherapy and pharmacology, 1988, Volume: 22, Issue:3

    Topics: Antibiotics, Antineoplastic; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cell Count; Coloring Agents; Drug Screening Assays, Antitumor; Humans; Lung Neoplasms; Mitomycins; Oxazines; Tetrazolium Salts; Thiazoles; Time Factors; Tumor Cells, Cultured

1988
A new antitumor antibiotic FR66973: clonogenic in vitro assessment of activity against human non-small cell lung carcinoma.
    Investigational new drugs, 1987, Volume: 5, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Carcinoma, Non-Small-Cell Lung; Colony-Forming Units Assay; Drug Screening Assays, Antitumor; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycins; Tumor Stem Cell Assay

1987